U
Oncologix Tech, Inc. OCLG
$0.0001 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

05/31/2016 05/31/2015
Total Cash And Short-Term Investments -28.38% -35.35%
Total Receivables -3.86% 342.97%
Inventory -23.29% 338.98%
Prepaid Expenses -38.69% -57.39%
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets -8.66% 163.75%

Total Current Assets -8.66% 163.75%
Net Property, Plant & Equipment -25.57% -20.18%
Long-term Investments -24.59% 34.94%
Goodwill -24.59% 34.94%
Total Other Intangibles -30.65% -23.46%
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets -17.76% 44.42%
Total Assets -19.06% 60.23%

Total Accounts Payable -33.27% 27.56%
Total Accrued Expenses 258.22% 46.25%
Short-term Debt 20.50% 162.40%
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 74.42% -13.88%
Total Finance Division Other Current Liabilities -42.30% --
Total Other Current Liabilities -42.30% --
Total Current Liabilities 14.85% 107.76%

Total Current Liabilities 14.85% 107.76%
Long-Term Debt -12.31% -42.29%
Short-term Debt 20.50% 162.40%
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -- --
Total Liabilities 12.82% 74.01%

Common Stock & APIC 0.98% 2.21%
Retained Earnings -3.72% -3.64%
Treasury Stock & Other -- --
Total Common Equity -116.09% -141.27%

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 0.00% 0.00%
Preferred Stock, Others -- --
Total Preferred Equity 0.00% 0.00%

Total Common Equity -116.09% -141.27%
Total Preferred Equity 0.00% 0.00%
Total Minority Interest -- --
Total Equity -116.11% -141.32%